Holdings
Novo Holdings A/S
As of Jun 30, 2026, Novo Holdings A/S reported 23 positions worth US$1.65B. Largest: Edgewise Therapeutics, Inc., Asml Holding Nv and Hemab Therapeutics Holdings, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | 5.35M | US$217M | no change | Jun 30, 2026 |
| Asml Holding Nv | 94,946 | US$189M | no change | Jun 30, 2026 |
| Hemab Therapeutics Holdings, Inc. | 4.18M | US$154M | new | Jun 30, 2026 |
| Brookfield Corporation | 3.5M | US$150M | no change | Jun 30, 2026 |
| Maplight Therapeutics, Inc. | 3.69M | US$132M | no change | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 1.13M | US$132M | −200K | Jun 30, 2026 |
| Avalyn Pharma Inc. | 3.88M | US$128M | new | Jun 30, 2026 |
| Salesforce, Inc. | 393K | US$61.6M | no change | Jun 30, 2026 |
| Arrivent Biopharma, Inc. | 1.5M | US$52.1M | −442K | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 1M | US$50.8M | −280K | Jun 30, 2026 |